Clinical Trial Supplies

World Market Report

MCP21475

EXECUTIVE ENGAGEMENTS

POOL

712
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

142
Interactions with Platform & by Email

PARTICIPANTS

28
Unique # Participated

VALIDATIONS

12
Responses Validated*

COMPANIES

33
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

22

PAGES

89

EDITION

8

PRICE

USD 5600

CODE

MCP21475


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What's New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Clinical Trial Supplies Market to Reach $2.8 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Clinical Trial Supplies estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at a CAGR of 4.7% over the analysis period 2020-2027. Phase I, one of the segments analyzed in the report, is projected to record a 5.4% CAGR and reach US$418.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Phase II segment is readjusted to a revised 4.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $597.2 Million, While China is Forecast to Grow at 4.4% CAGR
The Clinical Trial Supplies market in the U.S. is estimated at US$597.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$498 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Phase III Segment to Record 4.9% CAGR
In the global Phase III segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$843 Million in the year 2020 will reach a projected size of US$1.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

SELECT PLAYERS

Almac Group; Bilcare Limited; Biocair; Capsugel (Part of Lonza Group); Catalent, Inc.; CSM- Clingen Company; Eurofins Scientific; Infosys Limited; KLIFO A/S; Marken (A Subsidiary of UPS); Metrics Contract Services; N-Side; O&M Movianto (Part of Owens & Minor); Parexel International Corporation; PCI Services; PRA Health Sciences, Inc.; Seveillar Clinical Trial Supplies Pvt. Ltd.; SIRO Clinpharm Pvt. Ltd.; Thermo Fisher Scientific, Inc.; UDG Healthcare PLC.

SEGMENTS

» Phase (Phase I, Phase II, Phase III, Other Phases) » End-Use (Pharmaceutical, Biologics, Medical Device, Other End-Uses)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Clinical Trial Supplies – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Clinical Trial Supplies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Clinical Trial Supplies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Clinical Trial Supplies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Phase I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Phase I by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Phase I by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Phase II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Phase II by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Phase II by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Phase III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Phase III by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Phase III by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Clinical Trial Supplies Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
World Recent Past, Current & Future Analysis for Other Phases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Phases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Phases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Medical Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
UNITED STATES
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Clinical Trial Supplies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Clinical Trial Supplies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Clinical Trial Supplies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Clinical Trial Supplies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Clinical Trial Supplies by Phase - Phase I, Phase II, Phase III and Other Phases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Clinical Trial Supplies by Phase - Percentage Breakdown of Value Sales for Phase I, Phase II, Phase III and Other Phases for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Clinical Trial Supplies by End-Use - Pharmaceutical, Biologics, Medical Device and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Clinical Trial Supplies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biologics, Medical Device and Other End-Uses for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com